Tagged With Aimmune

Aimmune Therapeutics soars 172% after Nestle agrees to acquire the peanut allergy treatment company for $2.6 billion

Matthew Fox

A treatment for the most common food allergy could be available next year, and one biotech just drew ahead in the race for the $3 billion market

Emma Court

A pill to treat peanut allergies is getting closer to reality — but a new study shows the drug can have some harsh side effects

Lydia Ramsey

An experimental treatment for peanut allergies just succeeded in a key trial

Lydia Ramsey